NCT01918033

A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)

A Phase III, Multi-Center, Randomized, Parallel-Group, Placebo-Controlled and Double- Blind Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Perennial Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 608 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

This is a study to evaluate the efficacy and safety of desloratadine (MK-4117) in Japanese participants with perennial allergic rhinitis. The primary hypothesis is that desloratadine is superior to placebo after 2 weeks of treatment with regard to change from baseline in Total Nasal Symptom Score among Japanese participants with perennial allergic rhinitis.

Conditions

• Perennial Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Desloratadine 5 mg	Desloratadine 5 mg tablets
DRUG	Placebo	Matching placebo to desloratadine 5 mg tablets

Timeline

• Start date: 2013-08-20
• Primary completion: 2014-01-26
• Completion: 2014-01-26
• First posted: 2013-08-07
• Last updated: 2024-06-18
• Results posted: 2014-08-15